Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych VivasAddiction psychiatry

Psych Vivas · Addiction psychiatry

Alcohol use disorder — structured clinical viva

Fellowship viva on delirium tremens, CIWA-Ar, thiamine/Caine, naltrexone opioid trap, acamprosate/disulfiram doses, dual diagnosis pointer.

clinical1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. A 47-year-old with severe alcohol dependence is day two after emergency admission. Last drink about 50 hours ago. He is sweaty, tachycardic, fluctuating orientation, describing insects on the bed. Nursing staff ask whether this is 'just behavioural' and whether antipsychotics first are enough. His partner wants naltrexone started tonight while he is still on PRN oxycodone for rib fractures. Defend diagnosis, differentials, emergency management with doses, Wernicke prevention, and longer-term pharmacotherapy/psychosocial plan.

Interpretation

Reveal interpretationShowHide

Diagnosis. Delirium tremens — ~50 hours after last drink, fluctuating consciousness, severe autonomic hyperactivity, formed hallucinations. This is a medical emergency, not a primary behavioural disturbance.[1]

Differential. Other delirium (infection, metabolic, head injury from trauma), Wernicke encephalopathy (may coexist), alcohol hallucinosis without full delirium, benzo withdrawal if co-dependent, hepatic encephalopathy if cirrhotic.[1][3][6]

Immediate management. Continuous monitoring; CIWA-Ar if usable but do not withhold treatment if unassessable; high-dose benzodiazepines titrated to control agitation/autonomics (agent choice: diazepam or lorazepam if liver disease — name local protocol); parenteral thiamine high-dose if Wernicke risk; electrolytes (Mg/K/phosphate); medical/ICU escalation if refractory. Antipsychotics are not first-line for DT physiology.[1][2][6]

Naltrexone tonight. No while on oxycodone — precipitated opioid withdrawal and blocked analgesia. After opioid-free interval and consent, oral naltrexone 50 mg daily (or XR-NTX later) is reasonable; alternatives acamprosate 666 mg TDS or supervised disulfiram. Pair with psychosocial care; cite COMBINE nuances if asked.[4][5]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Mayo-Smith MF Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA, 1997.PMID 9214531
  2. [2]Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict, 1989.PMID 2597811
  3. [3]Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry, 1997.PMID 9010400
  4. [4]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. Am J Psychiatry, 2018.PMID 29301420
  5. [5]Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA, 2006.PMID 16670409
  6. [6]Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol, 2010.PMID 20642790
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAddiction in older adults — structured clinical vivaAddiction psychiatryNextAlcohol withdrawal and delirium tremens — structured clinical vivaAddiction psychiatry